Literature DB >> 27794473

Strongyloidiasis in Ontario: Performance of diagnostic tests over a 14-month period.

Michelle Dao Dong1, Nessika Karsenti2, Rachel Lau3, Filip Ralevski3, Karamjit Cheema3, Laura Burton3, Michael Klowak4, Andrea K Boggild5.   

Abstract

BACKGROUND: We evaluated the performance of stool microscopy, serology, and real time PCR (qPCR) for the diagnosis of strongyloidiasis at our reference laboratory.
METHODS: Using a convenience sample of specimens submitted between April 1, 2014 and May 31, 2015, positivity rates and performance characteristics were calculated.
RESULTS: During the enrolment period, 17,933 stool specimens were examined for O&P, 14 of which were positive for Strongyloides larvae. For stool specimens serially positive for larvae, mean duration of larval shedding was 12.7 days following the initial positive specimen, while for sputum and urine, it was 12 and 2 days, respectively. During the enrolment period, 3258 specimens were processed for Strongyloides serology, 200 of which were reactive (6.1%), 210 indeterminate (6.5%), and 2848 non-reactive (87.4%). qPCR was positive in 11 of 12 (91.7%) stool specimens containing larvae, and negative in all stool specimens without larvae by microscopy. There was no cross-reactivity of Strongyloides-specific qPCR to other stool protozoa or helminths.
CONCLUSIONS: In the absence of immunosuppression, larval burden in strongyloidiasis is low, limiting the utility of microscopy, and favoring serologic testing. However, false negative serology can occur in those with hyperinfection necessitating a combined diagnostic approach. qPCR was insufficiently sensitive to replace microscopy for detection of larvae.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Disseminated strongyloidiasis; Neglected tropical diseases; Serology; Soil-transmitted helminths; Stool microscopy

Mesh:

Year:  2016        PMID: 27794473     DOI: 10.1016/j.tmaid.2016.10.011

Source DB:  PubMed          Journal:  Travel Med Infect Dis        ISSN: 1477-8939            Impact factor:   6.211


  4 in total

1.  Acute strongyloidiasis in a child recently returned from vacation in Cuba.

Authors:  Ajibola Alabi; Andrea K Boggild; Ari Bitnun
Journal:  CMAJ       Date:  2017-11-20       Impact factor: 8.262

2.  Case Report: Ivermectin and Albendazole Plasma Concentrations in a Patient with Disseminated Strongyloidiasis on Extracorporeal Membrane Oxygenation and Continuous Renal Replacement Therapy.

Authors:  Carl Boodman; Yashpal S Chhonker; Daryl J Murry; Allison Mah; Jennifer Grant; Theodore Steiner; Michael Libman; Cesilia Nishi; Marthe Charles
Journal:  Am J Trop Med Hyg       Date:  2018-11       Impact factor: 2.345

3.  Evaluation of Two DNA Extraction Methods for Detection of Strongyloides stercoralis Infection.

Authors:  Beatrice Barda; Rahel Wampfler; Somphou Sayasone; Khampheng Phongluxa; Syda Xayavong; Khonsavanh Keoduangsy; Christian Schindler; Jennifer Keiser
Journal:  J Clin Microbiol       Date:  2018-03-26       Impact factor: 5.948

4.  Implementation and evaluation of a quality and safety tool for ambulatory strongyloidiasis patients at high risk of adverse outcome.

Authors:  Sabrina H M Yeung; Omar Mourad; Michael Klowak; Adrienne J Showler; Stefanie Klowak; Andrea K Boggild
Journal:  Trop Dis Travel Med Vaccines       Date:  2019-04-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.